Implantable biomaterial based on click chemistry for targeting small molecules

Acta Biomaterialia

Volumn 10, Issue 12, 2014, Pages 5099-5105

  Mejía Oneto, José M ^a   Gupta, Munish ^a   Leach, J Kent ^a,b   Lee, Mark ^a   Sutcliffe, Julie L ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Davis   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alginate; Click chemistry; Drug delivery; Hydrogel; In vivo imaging

Indexed keywords

BIOMATERIALS; CONTROLLED DRUG DELIVERY; HYDROGELS; MOLECULES; TARGETED DRUG DELIVERY;

CLICK CHEMISTRY; IN-VIVO; IN-VIVO IMAGING; MEDICAL CONDITIONS; MEDICAL THERAPY; OPTIMAL TREATMENT; SIDE EFFECT; SMALL MOLECULES; TARGETED DELIVERY; TECHNOLOGICAL ADVANCES;

SYNTHESIS (CHEMICAL);

ALGINIC ACID; ALKENE; CYCLOOCTENE; INDIUM 111; TETRAXETAN I 111; UNCLASSIFIED DRUG; DRUG IMPLANT; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MODIFICATION; CLICK CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIELS ALDER REACTION; DRUG DELIVERY SYSTEM; GEL; IMPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG IMPLANT; FEMALE; MATERIALS TESTING; MOLECULARLY TARGETED THERAPY; PROCEDURES; SYNTHESIS;

ALGINATES; ANIMALS; CLICK CHEMISTRY; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; MATERIALS TESTING; MICE; MICE, INBRED BALB C; MOLECULAR TARGETED THERAPY;

EID: 84925664793     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.08.019     Document Type: Article

References (38)

1. Kearney CJ, Mooney DJ. Macroscale delivery systems for molecular and cellular payloads. Nat Mater 2013; 12: 1004-17.
2. Hickok NJ, Shapiro IM. Immobilized antibiotics to prevent orthopaedic implant infections. Adv Drug Deliv Rev 2012; 64: 1165-76.
3. Velema WA, van der Berg JP, Hansen MJ, Szymanski W, Driessen AJM, Feringa BL. Optical control of antibacterial activity. Nat Chem 2013; 5: 924-8.
4. Lee JH, Chen KJ, Noh SH, Garcia MA, Wang H, Lin WY, et al. On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles. Angew Chem Int Ed Engl 2013; 52: 4384-8.
5. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008; 7: 771-82.
6. Piddock LJ. The crisis of no new antibiotics - what is the way forward? Lancet Infect Dis 2012; 12: 249-53.
7. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 2002; 99: 7687-92.
8. Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin Infect Dis 2013; 56: 1445-50.
9. Antimicrobial Resistance: Global Report on Surveillance 2014. Geneva: World Health Organization, http://www.who.int/iris/bitstream/10665/112642/1/9789241564748-eng.pdf; 2014 [accessed 5.5.2014].
10. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37-43.
11. Parekh AK, Barton MB. The challenge of multiple comorbidity for the US health care system. JAMA 2010; 303: 1303-4.
12. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716-24.
13. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004; 164: 1957-9.
14. Holman JE, Stoddard GJ, Higgins TF. Rates of prescription opiate use before and after injury in patients with orthopaedic trauma and the risk factors for prolonged opiate use. J Bone Joint Surg Am 2013; 95: 1075-80.
15. Laurencin CT, Khan Y. Regenerative engineering. Sci Transl Med 2012; 4 (160): ed9.
16. Pashuck ET, Stevens MM. Designing regenerative biomaterial therapies for the clinic. Sci Transl Med 2012; 4 (160): sr4.
17. Tibbitt MW, Anseth KS. Dynamic microenvironments: the fourth dimension. Sci Transl Med 2012; 4 (160): ps24.
18. Mejia-Oneto JM, Padwa A. Application of the Rh (II) cyclization/cycloaddition cascade for the total synthesis of (+/-)-aspidophytine. Org Lett 2006; 8: 3275-8.
19. Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed Engl 2001; 40: 2004-21.
20. Devaraj NK, Thurber GM, Keliher EJ, Marinelli B, Weissleder R. Reactive polymer enables efficient in vivo bioorthogonal chemistry. Proc Natl Acad Sci U S A 2012; 109: 4762-7.
21. Stairs S, Neves AA, Stockmann H, Wainman YA, Ireland-Zecchini H, Brindle KM, et al. Metabolic glycan imaging by isonitrile-tetrazine click chemistry. ChemBioChem 2013; 14: 1063-7.
22. Rossin R, Verkerk PR, van den Bosch SM, Vulders RC, Verel I, Lub J, et al. In vivo chemistry for pretargeted tumor imaging in live mice. Angew Chem Int Ed Engl 2010; 49: 3375-8.
23. Zeglis BM, Sevak KK, Reiner T, Mohindra P, Carlin SD, Zanzonico P, et al. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry. J Nucl Med 2013; 54: 1389-96.
24. Rossin R, Lappchen T, van den Bosch SM, Laforest R, Robillard MS. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody. J Nucl Med 2013; 54: 1989-95.
25. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999; 20: 45-53.
26. Jose S, Hughbanks ML, Binder BY, Ingavle GC, Leach JK. Enhanced trophic factor secretion by mesenchymal stem/stromal cells with glycine-histidine-lysine (GHK)-modified alginate hydrogels. Acta Biomater 2014; 10: 1955-64.
27. Royzen M, Yap GP, Fox JM. A photochemical synthesis of functionalized trans-cyclooctenes driven by metal complexation. J Am Chem Soc 2008; 130: 3760-1.
28. Blackman ML, Royzen M, Fox JM. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. J Am Chem Soc 2008; 130: 13518-9.
29. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307: 58-62.
30. Rossin R, van den Bosch SM, Ten Hoeve W, Carvelli M, Versteegen RM, Lub J, et al. Highly reactive trans-cyclooctene tags with improved stability for Diels-Alder chemistry in living systems. Bioconjug Chem 2013; 24: 1210-7.
31. Jose B, Antoci Jr V, Zeiger AR, Wickstrom E, Hickok NJ. Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus. Chem Biol 2005; 12: 1041-8.
32. Antoci Jr V, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthop Relat Res 2007; 461: 88-95.
33. Antoci Jr V, Adams CS, Parvizi J, Ducheyne P, Shapiro IM, Hickok NJ. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin Orthop Relat Res 2007; 461: 81-7.
34. Antoci Jr V, King SB, Jose B, Parvizi J, Zeiger AR, Wickstrom E, et al. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res 2007; 25: 858-66.
35. Antoci Jr V, Adams CS, Parvizi J, Davidson HM, Composto RJ, Freeman TA, et al. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycinmodified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 2008; 29: 4684-90.
36. Ketonis C, Adams CS, Barr S, Aiyer A, Shapiro IM, Parvizi J, et al. Antibiotic modification of native grafts: improving upon nature's scaffolds. Tissue Eng Part A 2010; 16: 2041-9.
37. Ketonis C, Barr S, Adams CS, Hickok NJ, Parvizi J. Bacterial colonization of bone allografts: establishment and effects of antibiotics. Clin Orthop Relat Res 2010; 468: 2113-21.
38. Ketonis C, Barr S, Adams CS, Shapiro IM, Parvizi J, Hickok NJ. Vancomycin bonded to bone grafts prevents bacterial colonization. Antimicrob Agents Chemother 2011; 55: 487-94.